In the larger SELECT trial in 2023, patients with heart failure, atherosclerotic disease, and overweight or obesity, treated with semaglutide 2.4 mg showed reduction in major adverse cardiac events (MACE) and heart failure end points regardless of heart failure subgroup being HFrEF or HFpEF [56,57,58]
The study "Liraglutide versus placebo as an adjunct to glucose-lowering therapy in patients with type 2 diabetes and moderate renal failure" (LIRA-RENAL) did not demonstrate a benefit of liraglutide in lowering eGFR, although the duration of the study (26 weeks) may have been insufficient to show an effect
Symptoms related to sulfur burps Sulfur burps can be a solo act or appear alongside other symptoms
Assessing the patients social situation helps identify potential barriers to diabetes treatment and education
Medical supervision is essential because even low doses affect blood sugar, appetite, and hormone signaling
They can offer specific tips that may help relieve this symptom